Effects of levosimendan in patients with acute heart failure and cardiorenal syndrome

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Cardiorenal syndrome (CRS) is common in patients with acute heart failure (AHF) and is associated with poor prognosis. Levosimendan (LVS) is an inodilator used in AHF and has beneficial effects on renal function (RF). However, it...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Heart J Acute Cardiovasc Care
Autori principali: Ribeiro Da Silva, M, Santos Silva, G, Caeiro, D, Passos Silva, M, Guerreiro, C, Teixeira, P, Ribeiro Queiros, P, Brandao, M, Ferreira, D, Sousa, O, Dias, A, Rodrigues, A, Braga, P
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2021
Soggetti:
16.4.1 - Pharmacotherapy
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264012/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.028
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi